| ID | Age | Sex | State | Date โผ | Onset Days | Vaccine | Manufacturer | Lot # | Symptoms | Narrative | ๐ | ๐ฅ | ๐ | โฟ | โ ๏ธ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2850943 | 39 | F | NC | 07/24/2025 |
COVID19 COVID19 COVID19 COVID19 COVID19 COVID19 |
PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH |
|
Agnosia, Anxiety, Aphasia, Balance disorder, C-reactive protein increased; Conve...
Agnosia, Anxiety, Aphasia, Balance disorder, C-reactive protein increased; Conversion disorder, Depression, Dizziness, Dysgraphia, Dysphemia; Electromyogram, Endotracheal intubation, Facial paralysis, Fatigue, Feeling abnormal; Fibrin D dimer increased, Gait inability, Headache, Hypoaesthesia oral, Immediate post-injection reaction; Immunisation reaction, Magnetic resonance imaging head normal, Pain in extremity, Pneumonia aspiration, Respiratory disorder; Thrombosis, Unresponsive to stimuli, Visual impairment, Walking aid user
More
|
After her second injection she immediately stated that the arm she received the injection in started...
After her second injection she immediately stated that the arm she received the injection in started with unbearable pain, then terrible headache later that night. The next day was having breathing issues, had to call the rescue squad, told her to go to the hospital, became unresponsive, had to intubate her, stayed for several nights, then discharged her with adverse reaction to the vaccine, one doctor admitted it, after discharge fatigued, respiratory , vision started changed, got pneumonia in the hospital but they said was aspiration pneumonia, took a long time to see specialists like pulmonologist, 3 weeks Dec 4 visiting the mom, looked like having a stroke, went to the hospital, was stuttering really badly, started left face drooping, was fine that morning, out with her kids, went to put something in the garbage, lost her balance and realized she was not ok, felt dizzy, her grandma helped her then mouth started going numb, then couldn't talk or write, looked spacy, failed the test for a stroke, by the time she got to the hospital, couldn't recognize objects, they gave her TPA to flush out a blood clot, transferred to another hospital. Later that morning starting talking a little better, did an MRI and that was normal, says didn't have a stroke, they tried to discharge her before they even tried to get her to walk, realized she couldn't walk, Tuesday they brought her a walker and discharged her to home, dx'd with conversion disorder, Mom had to fight for her to get better care, due to lack of insurance coverage in spite of working for the federal government. once they realized things changed completely, they assumed she didn't have any coverage. Then got her PT, then stayed two more weeks, no PT though only when the requesting facility were asking for the PT notes but there were none, psychiatry came and talked to her. She says her speech was worse so hard to advocate for herself. After discharge saw two psychiatric doctors outside the hospital, they said she had depression and anxiety but only developed this due to the treatment, she says they never requested her previous records from when she was intubated, wasn't depressed then but now is depressed. Says then was still hopeful because she didn't understand the magnitude of what happened. The whole left side is in pain, the stuttering comes and goes but worse when anxious, angry, or tired, doing speech therapy, learning to slow down, Since then went to neurology who is calling it conversion disorder, has found now there are cases like hers with the same side effects. They are new to the area, found a new PCP but they never touched her after 3 visits. mom kept having to ask for help but no referrals made, the doctor only gave a few weeks off with no restrictions, doing PT, OT, ST, went to ortho who says she looks like a stroke but he felt like he couldn't go over the Neuro or PCP, needs to do EMG test prior to her next MRI.
More
|
โ | โ | โ | |||
| 2850944 | 63 | F | WA | 07/24/2025 |
PNC20 |
PFIZER\WYETH |
LN4927 |
Blood pressure increased, Dyspnoea
Blood pressure increased, Dyspnoea
|
-Shortness of breath lasting 24 hours - elevated BP up to 203/74
-Shortness of breath lasting 24 hours - elevated BP up to 203/74
|
||||||
| 2850945 | 74 | M | MO | 07/24/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
NDC: 58160-825- |
Pruritus, Rash, Urticaria
Pruritus, Rash, Urticaria
|
Rash & hives. They continue to come & go with itching
Rash & hives. They continue to come & go with itching
|
||||||
| 2851006 | 38 | F | CO | 07/24/2025 |
HPV9 |
MERCK & CO. INC. |
|
Exposure during pregnancy, Product use issue
Exposure during pregnancy, Product use issue
|
GARDASIL 9 was inadvertently administered to a 38 year old female patient who is 28 weeks pregnant; ...
GARDASIL 9 was inadvertently administered to a 38 year old female patient who is 28 weeks pregnant; no other AE; GARDASIL 9 was inadvertently administered to a 38 year old female patient who is 28 weeks pregnant; This spontaneous prospective pregnancy report was received from a physician and refers to a 38-year-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown pregnancy conception date, the patient became pregnant with the date of last menstrual period estimated as 13-DEC-2024. On 27-JUN-2025, the 28-week-pregnant patient was inadvertently vaccinated with an unspecified dose of human papillomavirus 9-valent vaccine, recombinant (GARDASIL 9) suspension for injection (dose, route of administration, anatomical location, lot # and expiration date were not reported) for prophylaxis (Exposure during pregnancy, Accidental exposure to product). No symptoms were reported. Pregnancy outcome and fetal outcome were unknown. Estimated delivery date was 19-SEP-2025. Lot# is being requested and will be submitted if received.
More
|
||||||
| 2851007 | AL | 07/24/2025 |
MMRV MMRV |
MERCK & CO. INC. MERCK & CO. INC. |
Z007214 |
No adverse event, Product storage error; No adverse event, Product storage error
No adverse event, Product storage error; No adverse event, Product storage error
|
patient did not experience any adverse side effects from administered dose; PROQUAD with a prior exc...
patient did not experience any adverse side effects from administered dose; PROQUAD with a prior excursion on 6/18/2025 and a current excursion on 07/02/2025 that was administered post excursion to a patient on 07/01/2025; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 01-Jul-2025, the patient was vaccinated with and improper storage dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Z007214, expiration date: 05-Oct-2026), dose number 1, (0.5ml/once) (anatomical location and administration route were not reported) as prophylaxis; diluted in a sterile diluent (MERCK STERILE DILUENT), (lot # and expiration date were not reported), administered as prophylaxis. The reported stated that the Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) vaccine had a prior excursion on 18-Jun-2025 (of 6.8 Fahrenheit degrees (F) for 47 minutes) and a current excursion on 02-Jul-2025 (of 8.6 F for 1 hour, 17 minutes); that was administered post excursion to a patient on 01-Jul-2025. The nurse confirmed that the patient did not experience any adverse side effects.; Reporter's Comments: Keywords :
More
|
||||||||
| 2851008 | MO | 07/24/2025 |
VARCEL |
MERCK & CO. INC. |
Y015108 |
No adverse event, Product storage error
No adverse event, Product storage error
|
No symptoms reported; HCP called to report a temperature excursion for VARIVAX and PROQUAD. HCP repo...
No symptoms reported; HCP called to report a temperature excursion for VARIVAX and PROQUAD. HCP reported that VARIVAX and PROQUAD were administered to multiple patients on multiple dates after being improperly stored. This case pertains to one patient who received imprope; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 24-Jun-2025, the patient was vaccinated with an improper storage dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), (lot #Y015108, expiration date: 06-Sep-2026), dose number 1, (0.5 mL)(anatomical location and administration route were not reported); diluted in a sterile diluent (MERCK STERILE DILUENT), (lot # and expiration date were not reported), administered as prophylaxis. The reporter stated that Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) and Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) were administered to multiple patients on multiple dates after being improperly stored. However, this case pertains to one patient who received improperly stored Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) on 24-Jun-2025. No symptoms were reported. It was confirmed that the vaccine had a temperature excursion of 6.3 Fahrenheit degrees (F), during a time frame of 16 minutes.
More
|
||||||||
| 2851009 | 36 | F | PA | 07/24/2025 |
PNC21 |
MERCK & CO. INC. |
Z002626 |
No adverse event, Product storage error
No adverse event, Product storage error
|
No additional adverse event; A HCP called to report a TE for CAPVAXIVE. The HCP stated that sometime...
No additional adverse event; A HCP called to report a TE for CAPVAXIVE. The HCP stated that sometime during 06/27/2025 through 07/09/2025 the CAPVAXIVE was exposed to a minimum temperature of 0C and a maximum of 9C, but the HCP was unable to confirm when the excursions occurred; Information has been received from Business Partner/CRO on 09-Jul-2025. This spontaneous report was received from an Other health professional and refers to a 36-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 30-Jun-2025, the patient started therapy with Pneumococcal 21-valent Conjugate Vaccine (lot #Z002626, expiration date: 04-Sep-2026) 0.5 mL for an unknown indication. This vaccine was exposed to a minimum temperature of 0 degree Celsius and a maximum of 9 degree Celsius (Improper storage of product in use). No additional adverse event was reported.; Reporter's Comments:
More
|
||||||
| 2851010 | F | IL | 07/24/2025 |
HEP HEP |
MERCK & CO. INC. MERCK & CO. INC. |
|
Extra dose administered, No adverse event; Extra dose administered, No adverse e...
Extra dose administered, No adverse event; Extra dose administered, No adverse event
More
|
No additional AE/PQC reported; HCP calling to report an AE regarding the RECOMBIVAX HB vaccine. HCP ...
No additional AE/PQC reported; HCP calling to report an AE regarding the RECOMBIVAX HB vaccine. HCP reported that a female patient received the first two doses of the REOCMBIVAX HB vaccines on 09/05/2024 and 11/07/2024 respectively. HCP stated that the patient has not received her; This spontaneous report was received from a pharmacist and refers to a female patient of unknown age. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 05-Sep-2024, the patient was vaccinated with Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB), dose number 1, (lot # and expiration date were not reported). On 07-Nov-2024, the patient was vaccinated with Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB), dose number 2, (lot # and expiration date were not reported), both for prophylaxis (inappropriate schedule of product administration). Also, the patient has not received her third dose of the vaccine. No additional adverse event was reported (no adverse event).
More
|
|||||||
| 2851011 | 1 | MN | 07/24/2025 |
MMRV VARCEL VARCEL |
MERCK & CO. INC. MERCK & CO. INC. MERCK & CO. INC. |
Z006278 Z002625 |
Extra dose administered, No adverse event; Extra dose administered, No adverse e...
Extra dose administered, No adverse event; Extra dose administered, No adverse event; Extra dose administered, No adverse event
More
|
Inbound call from a HCP reporting a 12 month old was administered PROQUAD and VARIVAX. Request infor...
Inbound call from a HCP reporting a 12 month old was administered PROQUAD and VARIVAX. Request information on double dosing of Varicella, see request case 02839122. HCP declined to provide patient information. Lot and expiration dates were unknown fo; No additional AE; This spontaneous report was received from a nurse and refers to a 12-month-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date, the patient was vaccinated with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), (lot #Z002625, expiration date: 08-Jan-2027) and with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Z006278, expiration date: 15-Sep-2026) (overdose) for prophylaxis. The reporter requested information on double dosing of Varicella. No specific adverse effects reported (no adverse event).
More
|
|||||||
| 2851012 | 56 | M | MD | 07/24/2025 |
HPV9 HPV9 |
MERCK & CO. INC. MERCK & CO. INC. |
Y019459 Y019459 |
Aspiration joint, Blood test, Cardiac failure, Computerised tomogram, Condition ...
Aspiration joint, Blood test, Cardiac failure, Computerised tomogram, Condition aggravated; X-ray
More
|
heart failure exacerbation; This spontaneous report was received from a physician and refers to a 56...
heart failure exacerbation; This spontaneous report was received from a physician and refers to a 56-year-old male patient. The reporter stated that the patient was a Clinical Study participant enrolled in clinical trial for "GARDASIL 9" (however, no information regarding the study was reported). The patient's medical history was not reported. As concurrent conditions was reported "history" of heart failure. Concomitant therapies were not reported (discrepant information also reported that the patient "running out of medication" an unspecified medication). On 21-May-2025, the patient was vaccinated with the first dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (lot #Y019459, expiration date: 16-Feb-2027), dose number 1, (First Dose) (anatomical location and administration route were not reported) as prophylaxis. On 07-Jul-2025 (reported as "after a couple of weeks"), the patient experienced heart failure exacerbation. The reporting physician stated that patient was then admitted to the hospital on the same date 07-Jul-2025 for heart failure exacerbation due to "running out of medication". The reporter did not provide name of medication. During the hospitalization, some laboratory tests were performed (Aspiration of joint, blood work, X-Ray and computerized (CT) scan) but results were not provided. The patient recovered from the event on 11-Jul-2025 and was discharged from hospital on the same date. The physician stated that the event did not seem to be linked to vaccine with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) and categorized the heart failure exacerbation as serious, however reiterated the hospitalization appears to be due to running out of medication and not linked to vaccine.; Sender's Comments: Based on the clinically relevant information currently available for this individual case, the reported event of cardiac failure is considered unlikely related to the GARDASIL 9 vaccine. The evidence is not sufficient to suggest a relationship between the vaccine and the reported serious adverse event. The causality assessment is impacted by the confounding factors of the patient's concurrent condition of heart failure and the mentioned etiology of exacerbation as being out of medication. No changes to the product safety information are warranted at this time. Merck Sharp & Dohme LLC continues to monitor the safety profile of the product
More
|
โ | |||||
| 2851013 | VA | 07/24/2025 |
MMRV |
MERCK & CO. INC. |
Z002990 |
No adverse event, Product storage error
No adverse event, Product storage error
|
No symptoms or side effects were reported by HCP; HCP reporting that a patient received a dose of im...
No symptoms or side effects were reported by HCP; HCP reporting that a patient received a dose of improperly stored PROQUAD. Reference TE case #02843001. HCP reported that she did not know the date the excursion occurred, but knows the PROQUAD was administered following the excursion. HCP reported; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 26-Jun-2025, the patient was vaccinated with an improperly stored dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) lot #Z002990, expiration date: 14-Jul-2026, 0.5 mL (strength, route and anatomical location were not provided) for prophylaxis. The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (no details provided). The temperature excursion was: Temperature: 52.2๏ฟฝF, Time frame: Unknown by Reporter. No adverse event reported.
More
|
||||||||
| 2851014 | VA | 07/24/2025 |
MMRV |
MERCK & CO. INC. |
Z003309 |
No adverse event, Product storage error
No adverse event, Product storage error
|
No symptoms or side effects were reported by HCP; HCP reporting that a patient received a dose of im...
No symptoms or side effects were reported by HCP; HCP reporting that a patient received a dose of improperly stored PROQUAD. Reference TE case #02843001. HCP reported that she did not know the date the excursion occurred, but knows the PROQUAD was administered following the excursion. HCP reported; This spontaneous report was received from a nurse concerning a patient of unknown age and gender. The patient's pertinent medical history, past drug reactions or allergies, concurrent conditions and concomitant therapies were not provided. On 16-JUL-2025, the patient received a dose of improperly stored dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (lot #Z003309, has been verified to be valid, expiration date not reported but upon internal validation established as 21-JUL-2026) 0.5 mL (route, anatomical location were not reported) as prophylaxis. The health care professional (HCP) reported that she did not know the date the excursion occurred, but knew the Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) was administered following the excursion. No symptoms or side effects were reported. The operator of device was HCP. It was reported that the temperature was 52.2 farenheit (F), it was unknown time frame.
More
|
||||||||
| 2851015 | 40 | F | FL | 07/24/2025 |
MMR TDAP |
MERCK & CO. INC. GLAXOSMITHKLINE BIOLOGICALS |
Y005808 DY3K7 |
Headache, Musculoskeletal pain, Neck pain, Pain in extremity; Headache, Musculos...
Headache, Musculoskeletal pain, Neck pain, Pain in extremity; Headache, Musculoskeletal pain, Neck pain, Pain in extremity
More
|
LOCATION PAIN IN RIGHT ARM, LIMITED MOVEMENT, HEADACHE, NECK PAIN, SCAPULA PAIN, AFTER VACCINE DOSE
LOCATION PAIN IN RIGHT ARM, LIMITED MOVEMENT, HEADACHE, NECK PAIN, SCAPULA PAIN, AFTER VACCINE DOSE
|
||||||
| 2851016 | VA | 07/24/2025 |
MMRV |
MERCK & CO. INC. |
Z002990 |
No adverse event, Product storage error
No adverse event, Product storage error
|
No additional AE; a patient received a dose of improperly stored PROQUAD; This spontaneous report wa...
No additional AE; a patient received a dose of improperly stored PROQUAD; This spontaneous report was received from a nurse and refers to a(n) patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 03-Jun-2025, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), 0.5 mL, lot #Z002990, expiration date: 14-Jul-2026, administered for prophylaxis (route, strength and anatomical site were not reported) following temperature excursion (TE) occurred on unknown date (temperature: 52.2 F; timeframe: Unknown by Reporter) (Product storage error). The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot # and expiration date and other information were not reported). No symptoms or side effects were reported. No other information reported. No additional AE/No PQC (No adverse event).
More
|
||||||||
| 2851017 | 87 | F | GA | 07/24/2025 |
RSV |
GLAXOSMITHKLINE BIOLOGICALS |
jb27a |
Extra dose administered, No adverse event
Extra dose administered, No adverse event
|
Patient is okay. Arexvy was also given in 7-23-25
Patient is okay. Arexvy was also given in 7-23-25
|
||||||
| 2851018 | 17 | F | NC | 07/24/2025 |
MENB |
NOVARTIS VACCINES AND DIAGNOSTICS |
DC44A |
Syncope, Unresponsive to stimuli
Syncope, Unresponsive to stimuli
|
43.9kg 17 yo F with NKDA and history of syncope following vaccinations was given Bexsero vaccination...
43.9kg 17 yo F with NKDA and history of syncope following vaccinations was given Bexsero vaccination (lot # DC44A) IM in the right thigh ~1607 on 7/16. This was during a well visit. BP and HR prior to administration was 116/68 and 85. Afterward, the patient became syncopal and unresponsive. Patient quickly regained consciousness and appeared confused but reported feeling fine. Water and juice were offered. Initial blood pressure at 1610 was 99/57 lying down (no HR captured). Repeat blood pressure was 101/69 sitting at 1615. Patient was instructed to receive future vaccines and lab draws while lying down. Primary care provider was notified and spoke with both the patient and parent.
More
|
||||||
| 2851019 | 16 | F | AR | 07/24/2025 |
MNQ MNQ |
SANOFI PASTEUR SANOFI PASTEUR |
U8361AA U8361AA |
Abdominal pain upper, Dizziness, Headache, Injection site erythema, Injection si...
Abdominal pain upper, Dizziness, Headache, Injection site erythema, Injection site swelling; Injection site warmth
More
|
On 7/23/25 Dad reports at 2:30 am child was lying on bathroom floor at home complaining of dizziness...
On 7/23/25 Dad reports at 2:30 am child was lying on bathroom floor at home complaining of dizziness, headache, nausea, and stomach ache. Her left upper arm was red, slightly swollen, and warm to the touch. Dad took child's temperature and it was 99.9 F. Dad took child to ER to be evaluated. ER doctor dx given was allergic reaction. Medications ordered were Zofran and Zyrtec. Pt was discharged from ER ambulatory home with dad around 4:00 am. Dad reports child is currently at home sleeping. Dad has picture of child's left arm. Redness starts at upper deltoid and radiates down to nearly the elbow. Redness is splotchy and does not go all the way around the arm. ROI signed for ER records.
More
|
||||||
| 2851020 | 50 | F | FL | 07/24/2025 |
UNK |
UNKNOWN MANUFACTURER |
7ZM55 |
Inappropriate schedule of product administration
Inappropriate schedule of product administration
|
PATIENT RECEIVED SECOND SHINGRIX VACCINE TOO EARLY
PATIENT RECEIVED SECOND SHINGRIX VACCINE TOO EARLY
|
||||||
| 2851021 | 33 | F | VA | 07/24/2025 |
RAB |
NOVARTIS VACCINES AND DIAGNOSTICS |
fdp00553 |
Feeling abnormal, Lip swelling, Paraesthesia oral, Swelling face
Feeling abnormal, Lip swelling, Paraesthesia oral, Swelling face
|
C/o tingling sensation in tongue and feeling funny 4 mins after injection. No other symptoms noted ...
C/o tingling sensation in tongue and feeling funny 4 mins after injection. No other symptoms noted and client stated taking benadryl prior to visit. Nurse administered additional benadryl 25mg. Symptoms resolved at 25 min after benadryl and client left with instruction to seek medical attention if symptoms return. Client called at 4:25pm stating she started with lip and face swelling and went to local urgent care where she states she received steroid shot and Rx for steroid pack and was sent home. Attempted call to check in 7/24/25, left message on voicemail.
More
|
||||||
| 2851022 | 16 | M | VA | 07/24/2025 |
MENB MNQ |
NOVARTIS VACCINES AND DIAGNOSTICS SANOFI PASTEUR |
2P77Y U8573AA |
Vision blurred, Vomiting; Vision blurred, Vomiting
Vision blurred, Vomiting; Vision blurred, Vomiting
|
Patient walking out office, stopped and slowly lowered himself to the ground, closed his eyes for a ...
Patient walking out office, stopped and slowly lowered himself to the ground, closed his eyes for a few seconds, remained seated, put in wheelchair and wheeled into a room, pt vomited X1 and stated vision was blurry, legs elevated into another chair, sat until patient felt better, doctor examined and cleared. This event lasted about 20 minutes; he was wheeled to the vehicle with resolution of all symptoms.
More
|
||||||
| 2851023 | 54 | M | NC | 07/24/2025 |
PNC21 PNC21 |
MERCK & CO. INC. MERCK & CO. INC. |
Z004302 Z004302 |
Blood calcium decreased, Blood chloride increased, Blood creatinine normal, Bloo...
Blood calcium decreased, Blood chloride increased, Blood creatinine normal, Blood glucose normal, Blood magnesium normal; Blood potassium normal, Blood sodium decreased, Blood urea increased, Carbon dioxide decreased, Dizziness
More
|
54 y/o M with decompensated cirrhosis attributed to MASLD/MASH complicated by refractory ascites and...
54 y/o M with decompensated cirrhosis attributed to MASLD/MASH complicated by refractory ascites and bleeding esophageal varices, anxiety, and tobacco use who presented to hepatology clinic 7/16/25 for follow up and pretransplant evaluation. Baseline back pain 4/10. During clinic visit, patient was given pneumococcal 21 vaccine IM in the right deltoid at 0956. After administration, patient c/o dizziness, lightheadedness as they were walking to the front desk to check out. Patient escorted to exam room via w/c for VS recheck. VSS except for MAP 68. Patient drank approx. 5 oz.of water with resolution of dizziness with gradual improvement of lightheadedness. POC BG 97. Patient had eaten breakfast. At 1022, the pat
More
|
||||||
| 2851024 | 6 | F | MO | 07/24/2025 |
DTAP HEPA IPV MMRV |
GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS SANOFI PASTEUR MERCK & CO. INC. |
223Y9 H3N97 Y1A201M Y009348 |
Hypotonia, Pallor; Hypotonia, Pallor; Hypotonia, Pallor; Hypotonia, Pallor
Hypotonia, Pallor; Hypotonia, Pallor; Hypotonia, Pallor; Hypotonia, Pallor
|
Client observed her older brother receiving his vaccinations after she was done. She was sitting in ...
Client observed her older brother receiving his vaccinations after she was done. She was sitting in the same room beside her grandmother. As this nurse was administering her brother's last vaccination, client's grandmother started shouting. This nurse turned around to client on the floor partially sitting up but slumped down against the chair leg, eyes closed and pale skin. This nurse called out for help and then lifted client up onto the padded bench seat and she opened her eyes, she was able to answer questions properly regarding her name and who her grandmother is. Two other nurses came in to assist, bringing in a water bottle. Client's color started returning to her face, she was encouraged to take some deep breaths and also sip on the water. She stated she felt ok. After 15 minutes of recovery, client stated she felt fine and grandmother agreed they were ok to leave.
More
|
||||||
| 2851025 | 4 | F | FL | 07/24/2025 |
DTAPIPV DTAPIPV DTAPIPV MMR MMR MMR VARCEL VARCEL VARCEL |
GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS MERCK & CO. INC. MERCK & CO. INC. MERCK & CO. INC. MERCK & CO. INC. MERCK & CO. INC. MERCK & CO. INC. |
4L454 4L454 4L454 Y015020 Y015020 Y015020 Y020580 Y020580 Y020580 |
Activated partial thromboplastin time shortened, C-reactive protein increased, I...
Activated partial thromboplastin time shortened, C-reactive protein increased, Immature granulocyte count increased, Injection site swelling, Joint effusion; Lymphocyte percentage decreased, Neutrophil percentage increased, Platelet count normal, Purpura, Red blood cell sedimentation rate increased; White blood cell count increased, X-ray limb abnormal; Activated partial thromboplastin time shortened, C-reactive protein increased, Immature granulocyte count increased, Injection site swelling, Joint effusion; Lymphocyte percentage decreased, Neutrophil percentage increased, Platelet count normal, Purpura, Red blood cell sedimentation rate increased; White blood cell count increased, X-ray limb abnormal; Activated partial thromboplastin time shortened, C-reactive protein increased, Immature granulocyte count increased, Injection site swelling, Joint effusion; Lymphocyte percentage decreased, Neutrophil percentage increased, Platelet count normal, Purpura, Red blood cell sedimentation rate increased; White blood cell count increased, X-ray limb abnormal
More
|
slight swelling on L thigh on the 7/22/25; + increased swelling on the L thigh the next day and note...
slight swelling on L thigh on the 7/22/25; + increased swelling on the L thigh the next day and note of purpura on the back of both lower extremities; L knee swelling later that PM. No fever
More
|
||||||
| 2851026 | 52 | F | WI | 07/24/2025 |
HEP HEP PNC20 PNC20 TDAP TDAP |
GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS PFIZER\WYETH PFIZER\WYETH GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
9K34M 9K34M LP4946 LP4946 9JT4S 9JT4S |
Arthralgia, Blood creatine phosphokinase normal, C-reactive protein normal, Full...
Arthralgia, Blood creatine phosphokinase normal, C-reactive protein normal, Full blood count normal, Muscular weakness; Pain in extremity, Paraesthesia, Red blood cell sedimentation rate normal; Arthralgia, Blood creatine phosphokinase normal, C-reactive protein normal, Full blood count normal, Muscular weakness; Pain in extremity, Paraesthesia, Red blood cell sedimentation rate normal; Arthralgia, Blood creatine phosphokinase normal, C-reactive protein normal, Full blood count normal, Muscular weakness; Pain in extremity, Paraesthesia, Red blood cell sedimentation rate normal
More
|
Several hours after receiving immunizations in the rt arm, pt experienced weakness and pain in upper...
Several hours after receiving immunizations in the rt arm, pt experienced weakness and pain in upper arm . Was seen again on 6/30/25 and pain had settled in rt lateral shoulder; Also had some intermittent tingling rt thumb and first finger; Pain started in left upper arm also. she was treated with OTC Aleve and then a Medrol dose pack. She also was placed on Gabapentin 300 mg. She then was referred to physical therapy and their evaluation told her the pain was in her rotator cuffs and she is receiving treatment from Physical therapy with decreasing pain at this time.
More
|
||||||
| 2851027 | 17 | F | NE | 07/24/2025 |
MNQ MNQ HPV9 HPV9 TDAP TDAP |
NOVARTIS VACCINES AND DIAGNOSTICS NOVARTIS VACCINES AND DIAGNOSTICS MERCK & CO. INC. MERCK & CO. INC. GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
LN75D LN75D Y015599 Y015599 9JT4S 9JT4S |
Vaccination error; Wrong patient; Vaccination error; Wrong patient; Vaccination ...
Vaccination error; Wrong patient; Vaccination error; Wrong patient; Vaccination error; Wrong patient
More
|
Patient was given Menveo 0.5 ml in Right Deltoid in error at 1:20pm on 07/22/2025.
Patient was given Menveo 0.5 ml in Right Deltoid in error at 1:20pm on 07/22/2025.
|
||||||
| 2851028 | 39 | F | NJ | 07/24/2025 |
ANTH ANTH |
EMERGENT BIOSOLUTIONS EMERGENT BIOSOLUTIONS |
|
Asthenia, Blood test normal, Dyspnoea, Fatigue, Headache; Influenza virus test n...
Asthenia, Blood test normal, Dyspnoea, Fatigue, Headache; Influenza virus test negative, Pyrexia, Respiratory syncytial virus test negative, SARS-CoV-2 test negative
More
|
Fever, headache, shortness of breath, fatigue and weakness. Not pregnant. Headache for 3 days- start...
Fever, headache, shortness of breath, fatigue and weakness. Not pregnant. Headache for 3 days- started 4:30 am 7/15/2025-7/17/2025. Fever-started 1:36am 7/15/2025-7/16/2025. Shortness of breath- started 7/17-7/18. Fatigue and weakness- started 7/15-7-20. I was not given any medications because they were running blood test..I got the results on Friday 7/18.all results was negative by then the more severe symptoms was gone except weakness,fatigue and shortness of breath. I was told that it will take 2 weeks for my body to adjust to the vaccine..
More
|
||||||
| 2851029 | 12 | M | NE | 07/24/2025 |
MENB |
NOVARTIS VACCINES AND DIAGNOSTICS |
E549H |
No adverse event, Wrong patient
No adverse event, Wrong patient
|
Went to help administer vaccinations. She had already gotten shots pulled up and verified by anoth...
Went to help administer vaccinations. She had already gotten shots pulled up and verified by another nurse. That nurse was not able to help administer vaccinations so I did. I did not reverify shots. Said who to give what shots to. When we came out of room realized we switched the children and gave the wrong vaccinations to the wrong child. At that time no apparent effects were seen.
More
|
||||||
| 2851030 | 4 | F | FL | 07/24/2025 |
MMRV |
MERCK & CO. INC. |
Z007869 |
No adverse event
No adverse event
|
No notable symptoms at this time.
No notable symptoms at this time.
|
||||||
| 2851031 | 61 | F | GA | 07/24/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
23AH3 |
Pruritus, Skin irritation, Swelling face
Pruritus, Skin irritation, Swelling face
|
patient called and said that her face is swelling and had some irritation and itching some parts of ...
patient called and said that her face is swelling and had some irritation and itching some parts of the body
More
|
||||||
| 2851033 | 51 | F | NY | 07/24/2025 |
PNC20 VARZOS |
PFIZER\WYETH GLAXOSMITHKLINE BIOLOGICALS |
LX4482 2HJ99 |
Asthenia, Pain; Asthenia, Pain
Asthenia, Pain; Asthenia, Pain
|
Patient reported general body aches and weakness for one day.
Patient reported general body aches and weakness for one day.
|
||||||
| 2851035 | 19 | F | NE | 07/24/2025 |
DTAPHEPBIP |
GLAXOSMITHKLINE BIOLOGICALS |
9D25P |
No adverse event, Underdose
No adverse event, Underdose
|
patient received pediatric dose of medication. has not had any adverse effects at this time.
patient received pediatric dose of medication. has not had any adverse effects at this time.
|
||||||
| 2851036 | 1.25 | F | IA | 07/24/2025 |
PNC20 |
PFIZER\WYETH |
LN4930 |
Extra dose administered, No adverse event
Extra dose administered, No adverse event
|
Wrong vaccination given in error. This was a 5th dose, not needed. No reaction at time of injection....
Wrong vaccination given in error. This was a 5th dose, not needed. No reaction at time of injection. Was then given appropriate vaccination in left thigh. Dr. aware. Mother aware. Questions addressed.
More
|
||||||
| 2851037 | 12 | M | PA | 07/24/2025 |
HPV9 HPV9 MNQ MNQ TDAP TDAP |
MERCK & CO. INC. MERCK & CO. INC. SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR |
|
Dizziness, Dyskinesia, Fatigue, Muscle rigidity, Syncope; Tunnel vision; Dizzine...
Dizziness, Dyskinesia, Fatigue, Muscle rigidity, Syncope; Tunnel vision; Dizziness, Dyskinesia, Fatigue, Muscle rigidity, Syncope; Tunnel vision; Dizziness, Dyskinesia, Fatigue, Muscle rigidity, Syncope; Tunnel vision
More
|
Light headedness, tunnel vision and then syncope within 2-3 seconds of the final vaccine being admin...
Light headedness, tunnel vision and then syncope within 2-3 seconds of the final vaccine being administered with about 20 seconds of limb rigidity and arm/leg movements. He then woke up within about a minute and was able to converse. Was still tired but perked up after drinking some juice and eating a small snack.
More
|
||||||
| 2851038 | VA | 07/24/2025 |
MMRV |
MERCK & CO. INC. |
Y017516 |
No adverse event, Product storage error
No adverse event, Product storage error
|
No adverse event; a patient received a dose of improperly stored PROQUAD; This spontaneous report wa...
No adverse event; a patient received a dose of improperly stored PROQUAD; This spontaneous report was received from a Nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent condition, concomitant therapies were not reported. On an unknown date, the vaccine Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Y017516, expiration date: 19-Apr-2026) 0.5 mL (0.5mL) was temperature excursion to 52.2 degrees Fahrenheit for unknown time. The previous temperature excursion was N/A. On 09-Jun-2025, this vaccine was vaccinated to the patient for prophylaxis (strength, and route of administration were not provided) (Product storage error). No symptoms or side effects were reported by HCP. No other information reported by HCP. Consent to contact HCP was given. No additional adverse event.
More
|
||||||||
| 2851039 | 77 | F | PA | 07/24/2025 |
IPV |
SANOFI PASTEUR |
y1a212m |
Extra dose administered
Extra dose administered
|
Patient presented to the pharmacy verbally requesting a polio vaccine. Patient completed a vaccine c...
Patient presented to the pharmacy verbally requesting a polio vaccine. Patient completed a vaccine consent form for the vaccine. Pharmacist verified polio vaccine (IPOL) in pharmacy system. Patient was checked out at pharmacy register for IPOL vaccine. At the pharmacy register patient verbally confirmed that she was to receive the polio vaccine. Patient was asked to step into the Pharmacy's vaccine administration area. At this time Pharmacist confirmed patient name and date of birth. Patient's consent form stated she was interested in receiving "Prolio". Pharmacist verbally confirmed with the patient that she was to receive the polio vaccine, and patient confirmed. Patient asked if the polio vaccine was for bones. Pharmacist stated that the polio vaccine was used to prevent polio. Patient mentioned that she believed the vaccine was to be administered in the abdomen. Pharmacist stated that the vaccine prepared, inactivated polio vaccine (IPOL), was to be administered intramuscularly in the deltoid muscle. Patient consented to the administration. Vaccine was administered intramuscularly in patient's left deltoid muscle. After administration, patient returned to the pharmacy stating she believed she received the wrong injection. After further questioning, patient was interested in Prolia injection. Patient was informed that she had received and polio vaccine and not a Prolia injection and to contact her physician for a Prolia prescription. Patient reported no other symptoms or side effects at this time.
More
|
||||||
| 2851040 | 18 | M | TX | 07/24/2025 |
MNQ |
SANOFI PASTEUR |
U8493AA |
Dizziness, Pallor
Dizziness, Pallor
|
Pallor and lightheadedness about 1 min after vaccine administration. Student assisted to floor. Inte...
Pallor and lightheadedness about 1 min after vaccine administration. Student assisted to floor. Interventions- provided juice and icepack. Student denied further interventions and assessments. Student rested about 20 mins and regained skin color and was alert oriented and stable. Student was talking and walking and further monitored for additional 15 mins. Upon release from clinic student ambulatory and stable.
More
|
||||||
| 2851041 | 9 | M | IN | 07/24/2025 |
MNQ |
NOVARTIS VACCINES AND DIAGNOSTICS |
DL4yy |
Product administered to patient of inappropriate age
Product administered to patient of inappropriate age
|
MCV4 inadvertantly administered to a 9 year old. Menveo is licensed starting at age 10 years.
MCV4 inadvertantly administered to a 9 year old. Menveo is licensed starting at age 10 years.
|
||||||
| 2851042 | 49 | M | LA | 07/24/2025 |
HEP |
GLAXOSMITHKLINE BIOLOGICALS |
N733B |
Lip pruritus, Lip swelling, Swollen tongue, Tongue pruritus, Urticaria
Lip pruritus, Lip swelling, Swollen tongue, Tongue pruritus, Urticaria
|
Patient had severe hives and itching along with swelling to his lips and tongue. Treated with predni...
Patient had severe hives and itching along with swelling to his lips and tongue. Treated with prednisone, Decadron injection and Allegra daily.
More
|
||||||
| 2851043 | 48 | F | 07/24/2025 |
UNK |
UNKNOWN MANUFACTURER |
|
No adverse event, Product preparation issue
No adverse event, Product preparation issue
|
Pt was to receive MMR ( Priorix). I was not aware we were now using this vaccine. I took a syringe o...
Pt was to receive MMR ( Priorix). I was not aware we were now using this vaccine. I took a syringe out of the box which had clear liquid in it and prepared it to give to pt. After giving the "vaccine", I noticed the syringe said sterile water. I was not aware that this vaccine needed to be reconstituted. I informed the pt the I had given her sterile water and explained I would have to get the vaccine and reconstitute it. I apologized several times and patient understanding. Pt did not show any signs of adverse reaction. She left the clinic unaffected.
More
|
|||||||
| 2851044 | 81 | M | NC | 07/24/2025 |
VARZOS VARZOS VARZOS VARZOS VARZOS |
GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
2HJ99 2HJ99 2HJ99 2HJ99 2HJ99 |
Adrenal adenoma, Arthralgia, Bladder dilatation, Blood calcium increased, Blood ...
Adrenal adenoma, Arthralgia, Bladder dilatation, Blood calcium increased, Blood creatine phosphokinase; Blood creatinine increased, Blood parathyroid hormone, Blood thyroid stimulating hormone, Brain natriuretic peptide normal, Calcium ionised decreased; Computerised tomogram abdomen abnormal, Computerised tomogram head normal, Gastritis, Gastrointestinal wall thickening, Glomerular filtration rate increased; Neutrophil count, Pain, Red blood cell sedimentation rate, Troponin normal, Urinary retention; Vitamin B12, Vitamin D, White blood cell count increased, X-ray limb
More
|
Approximately 1 day following administration of the vaccination, patient began to experience severe ...
Approximately 1 day following administration of the vaccination, patient began to experience severe pain in the right shoulder which progressively worsened to diffuse, generalized pain particularly in his upper and lower extremities. He did seek ER treatment on July 20 as symptoms progressed. He was re-evaluated in my office on July 23, with little improvement.
More
|
||||||
| 2851045 | 1 | F | MI | 07/24/2025 |
IPV |
SANOFI PASTEUR |
X1D141M |
Extra dose administered, No adverse event
Extra dose administered, No adverse event
|
Patient was given extra dose of Polio vaccine. No adverse reaction.
Patient was given extra dose of Polio vaccine. No adverse reaction.
|
||||||
| 2851046 | 11 | M | NH | 07/24/2025 |
TDAP |
SANOFI PASTEUR |
U8252AA |
Circumstance or information capable of leading to medication error, Scratch
Circumstance or information capable of leading to medication error, Scratch
|
routine administration of Tdap vaccine. explained safe procedure or administration. Patient and MOC ...
routine administration of Tdap vaccine. explained safe procedure or administration. Patient and MOC expressed understanding. MOC wrapped both arms around patient stabilizing Left arm. expressed to hold very tight while Administration of vaccination is going on. MOC expressed understanding and stabilized patient. Patient moved within MOC arms. Vaccination was partially administered; patient received a 1-inch scratch from needle. scratch cleaned and band aid applied. MOC made aware of scratch and understood. Provider informed immediately. Immune team informed immediately. Patient will be coming back to clinic for repeat dose of Tdap.
More
|
||||||
| 2851047 | 30 | F | 07/24/2025 |
VARCEL |
MERCK & CO. INC. |
Y019319 |
Contraindication to vaccination, Peripheral swelling
Contraindication to vaccination, Peripheral swelling
|
Patient called about an hour after receiving vaccine and reported that her hands are swelling. She w...
Patient called about an hour after receiving vaccine and reported that her hands are swelling. She was told to go to the ER. Nurse contacted the patient later to see how she was doing. Patient reported that she still had swelling and that she had gone to an urgent care and was taking Benadryl. About an hour after that, the pt called back to ask if the varicella vaccine contained any bovine or animal products. Upon research, the CDC only reported that it had aluminum salt or a form of aluminum in it. But according to the FDA, the vaccine does contain gelatin and a residual component that is made from fetal bovine. The patient has Alpha-gal syndrome that causes her to react to animal products. The patient was contacted again today for a follow up and she stated that she still has swelling but is doing ok. Pt states that it can take a while for the swelling to reside, and that it's hard to tell how long she will be reactive post exposure. Nurse will continue to follow up.
More
|
|||||||
| 2851048 | 35 | F | KS | 07/24/2025 |
JEV1 |
INTERCELL AG |
|
Ocular discomfort, Vision blurred
Ocular discomfort, Vision blurred
|
Blurred vision in right eye. Slight pressure behind eye.
Blurred vision in right eye. Slight pressure behind eye.
|
||||||
| 2851049 | 55 | M | CA | 07/24/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
pj353 |
Contusion, Oedema peripheral
Contusion, Oedema peripheral
|
patient returned to the pharmacy 4 days(7/22) post vaccine asking for RPH to look at arm to see if r...
patient returned to the pharmacy 4 days(7/22) post vaccine asking for RPH to look at arm to see if reaction was normal. Patient presented with swelling and bruising on underarm and no injection site reactions. The swelling was significanted and marked on only the arm that the vaccination was administered on. The patient was advised by the pharmacy to speak to their physician regarding the potential reaction. The patient had a video visit that day(7/22) with their primary care md and when patient was contacted on 7/24 to follow up the patient stated the md told the patient is was unlikely to be an infection due to lack of redness and fever. Per the Patient the md advised the patient to follow up with their office if worsening or not resolved in a few day. As of 7/24 symptoms of swelling and bruising in the underarm area still present.
More
|
||||||
| 2851050 | 71 | F | OR | 07/24/2025 |
PNC21 |
MERCK & CO. INC. |
Z003579 |
Pain in extremity, Peripheral swelling, Skin warm
Pain in extremity, Peripheral swelling, Skin warm
|
She called Pharmacy and said day after shot her arm was swollen, hot and painful
She called Pharmacy and said day after shot her arm was swollen, hot and painful
|
||||||
| 2851051 | 5 | F | IN | 07/24/2025 |
DTAPIPV VARCEL |
GLAXOSMITHKLINE BIOLOGICALS MERCK & CO. INC. |
42Y93 Y005922 |
Erythema; Erythema
Erythema; Erythema
|
PT WAS VACCINATED ON MONDAY 7-21-25 AND WOKE UP WITH A 6 IN RED WARM CIRCLE ON HER ARM. MOM TOOK HER...
PT WAS VACCINATED ON MONDAY 7-21-25 AND WOKE UP WITH A 6 IN RED WARM CIRCLE ON HER ARM. MOM TOOK HER TO A WALK IN CLINIC AND THEY SAID IT WAS A TYPICAL REACTION. WE SPOKE ON 7/23/25 AND THE CIRCLE WAS GETTING LARGER- THE BORDERS HAD BEEN MARKED EARLIER, AND I ASKED MOM TO START TREATING HER WITH CLARITIN, ICE, AND BENADRYL CREAM. MOM FELT IT WAS GETTING WORSE THAT NIGHT SO THEY WENT TO THE ER AND SHE WAS GIVEN KEFLAX FOR POSSIBLE CELLULITIS. MOM STATES THE BORDERS WERE UP TO 10 IN AT THIS TIME.
More
|
||||||
| 2851052 | 77 | M | NY | 07/24/2025 |
FLU3 PNC21 VARZOS |
SANOFI PASTEUR MERCK & CO. INC. GLAXOSMITHKLINE BIOLOGICALS |
u8764bb yo19158 93n4j |
Loss of consciousness; Loss of consciousness; Loss of consciousness
Loss of consciousness; Loss of consciousness; Loss of consciousness
|
passed out at home next day per daughter
passed out at home next day per daughter
|
โ | |||||
| 2851053 | 9 | F | TX | 07/24/2025 |
HPV9 |
MERCK & CO. INC. |
Y015179 |
Injection site abscess, Injection site pain, Injection site swelling
Injection site abscess, Injection site pain, Injection site swelling
|
PATIENT RECEIVED FIRST HPV VACCINE ON 7/15/2025 ADMINISTERED IM TO LEFT UPPER ARM, ON 7/22/25 PATIEN...
PATIENT RECEIVED FIRST HPV VACCINE ON 7/15/2025 ADMINISTERED IM TO LEFT UPPER ARM, ON 7/22/25 PATIENT REPORTED SWELLING AND PAIN TO LEFT UPPER ARM, MOM ADMINISTERED IBUPROFEN AND APPLIED WARM COMPRESSES, ON 7/24/2025 PRESENTED TO CLINIC WHERE PCP DIAGNOSED WITH ABCESS AND INITIATED TREATMENT WITH clindamycin 75 mg/5 mL oral solution.
More
|
||||||
| 2851054 | 54 | F | CA | 07/24/2025 |
PNC20 PNC20 |
PFIZER\WYETH PFIZER\WYETH |
LX4484 LX4484 |
Bone pain, Chills, Dehydration, Fatigue, Headache; Peripheral swelling, Rash, Sk...
Bone pain, Chills, Dehydration, Fatigue, Headache; Peripheral swelling, Rash, Skin warm
More
|
The night after receiving the vaccine, patient developed rash on right arm, swelling, hotness, fever...
The night after receiving the vaccine, patient developed rash on right arm, swelling, hotness, fever, fatigue, chills, dehydration, headache and achy bones in her hand. She said she took Tylenol but it did not help. She came into the pharmacy 7/24 so pharmacist called md office to report incident. Patient was later seen and was prescribed Medrol Dose pack and Bactrim DS.
More
|